Henry Schein INC Stock: price and management transactions · United States · SEC (Form 4)Follow the Henry Schein INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Henry Schein INC has recorded 283 insider filings. Market capitalisation: €9.8bn. The latest transaction was reported on 30 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BERGMAN STANLEY M. The full history is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Henry Schein INC Buy (bullish), based on 16 analysts. Average price target: US$88.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,056 of 29,062 companies
FCF yld 5.2%
Earn yld 4.0%
EV/EBITDA 13.9x
ROE 8.9%
Gross mgn 31%
Net mgn 3.0%
Debt/EBITDA 3.6x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
All Executives283 Thresholds0 Prospectus0 Other0
Declarations 283 total
● Former Director · Executives · 30 Jun 2026
28,791 shares @ US$84.29 0.025% mcap 100.0% of flow Common SEC144:0001959173-26-004962
◆ Director · Executives · 12 Jun 2026
2,215 shares Common Stock, par value $0.01 per share SEC:0001190297-26-000004:0
● Director · Executives · 21 May 2026
50 shares 0Common Stock, par value $0.01 per share SEC:0001193125-26-237318:0
● Director · Executives · 19 May 2026
1,040 shares 0Common Stock, par value $0.01 per share SEC:0001193125-26-234868:0
▼ CEO, Henry Schein Products · Executives · 19 Mar 2026
1,355 shares @ US$72.79 53.6% of flow Common Stock, par value $0.01 per share SEC:0002057014-26-000008:0
● SVP, Chief Human Res. Officer · Executives · 16 Mar 2026
463 shares @ US$74.61 100.0% of flow Common Stock, par value $0.01 per share SEC:0002070926-26-000006:0
● CEO, Henry Schein Products · Executives · 16 Mar 2026
587 shares @ US$74.61 19.3% of flow Common Stock, par value $0.01 per share SEC:0002057014-26-000006:0
● CEO, Global Dist. & Tech. · Executives · 16 Mar 2026
1,401 shares @ US$74.61 56.1% of flow Common Stock, par value $0.01 per share SEC:0002025230-26-000006:0
● SVP & Chief Financial Officer · Executives · 16 Mar 2026
5,216 shares @ US$74.61 67.7% of flow Common Stock, par value $0.01 per share SEC:0001924845-26-000006:0
● EVP, Chief Strategic Officer · Executives · 16 Mar 2026
5,928 shares @ US$74.61 6.5% of flow Common Stock, par value $0.01 per share SEC:0001194352-26-000008:0
● EVP & Chief Operating Officer · Executives · 16 Mar 2026
1,300 shares 0Common Stock, par value $0.01 per share SEC:0001577158-26-000006:0
● Director · Executives · 16 Mar 2026
400 shares 0Common Stock, par value $0.01 per share SEC:0001008413-26-000008:0
● Director · Executives · 12 Mar 2026
970 shares 0Common Stock, par value $0.01 per share SEC:0001008413-26-000006:0
▼ Director · Executives · 10 Mar 2026
2,844 shares @ US$78.961 28.9% of flow Common Stock, par value $0.01 per share SEC:0001275613-26-000004:0
◆ SVP, Chief Human Res. Officer · Executives · 6 Mar 2026
7,087 shares 0Common Stock, par value $0.01 per share SEC:0002070926-26-000004:0
◆ CEO, Henry Schein Products · Executives · 6 Mar 2026
53,206 shares 0Common Stock, par value $0.01 per share SEC:0002057014-26-000004:0
◆ SVP & Chief Financial Officer · Executives · 6 Mar 2026
20,296 shares 0Common Stock, par value $0.01 per share SEC:0001924845-26-000004:0
◆ CEO · Executives · 6 Mar 2026
64,433 shares 0Common Stock, par value $0.01 per share SEC:0001777440-26-000007:0
◆ EVP & Chief Operating Officer · Executives · 6 Mar 2026
27,061 shares 0Common Stock, par value $0.01 per share SEC:0001577158-26-000004:0
● EVP, Chief Strategic Officer · Executives · 6 Mar 2026
300 shares 0Common Stock, par value $0.01 per share SEC:0001194352-26-000006:0
◆ CEO, Global Dist. & Tech. · Executives · 6 Mar 2026
60,631 shares 0Common Stock, par value $0.01 per share SEC:0002025230-26-000004:0
◆ Director · Executives · 6 Mar 2026
2,577 shares 0Common Stock, par value $0.01 per share SEC:0001898921-26-000002:0
◆ Director · Executives · 6 Mar 2026
2,577 shares 0Common Stock par value $0.01 per share SEC:0001883879-26-000002:0
◆ Director · Executives · 6 Mar 2026
2,577 shares 0Common Stock, par value $0.01 per share SEC:0001743156-26-000002:0
◆ Director · Executives · 6 Mar 2026
2,577 shares 0Common Stock, par value $0.01 per share SEC:0001580247-26-000002:0
25 of 283 declarations
Load more (258 remaining) 关于 Henry Schein INC Henry Schein Inc. 是面向办公室牙科和医疗执业者的领先医疗保健解决方案提供商。该公司在美国市场纳斯达克(美国)上市,成立于1932年,总部位于纽约梅尔维尔。最初作为一家专注于牙科的分销商,现已发展成为一个更广泛的医疗保健平台,为临床医生和诊所所有者提供耗材、设备、专业产品、软件和增值服务。
公司业务目前围绕三个核心部门组织。首先,全球分销和增值服务涵盖品牌和自有品牌商品、设备、技术服务以及咨询服务(如诊所转让、咨询、继续教育和金融服务)的销售。其次,全球专业产品包括牙科植入物和生物材料产品以及牙髓、正畸、骨科和其他医疗保健相关产品的制造、营销和销售。第三,全球技术包括诊所管理软件、电子服务和相关的数字解决方案。这种分销、专有产品和软件的组合创造了一个多元化的模式,具有经常性需求特征和广泛的客户群。
从竞争角度来看,Henry Schein 在牙科和医疗办公室供应链中占据强势地位,这得益于其规模、物流足迹、技术服务能力和综合产品。该公司在33个国家和地区开展业务,使其在美国本土市场之外具有重要的国际影响力。其竞争优势在与独立执业者的关系中尤为明显,在这些关系中,产品可用性、服务质量、软件集成和设备支持与价格同等重要。与此同时,该公司面临来自专业分销商、制造商和在线商务平台的激烈竞争。
近期发展对投资者而言非常重要。2025年1月,Henry Schein 宣布了KKR的战略投资、董事会变动以及价值创造合作框架。该公司还在2025年更新了其可报告部门结构,以更好地使外部报告与管理层对业务的内部看法保持一致。在运营方面,2025年的业绩突出了医疗分销、专业产品和技术的增长,这得益于牙科和医生诊所的潜在需求、收购以及不断扩展的基于云的软件产品,如Dentrix Ascend和Dentally。对于国际股票投资者而言,HSIC 代表着一个成熟的美国医疗保健特许经营权,具有全球影响力、有弹性的终端市场以及不断演变的多元化分销、专业制造和数字工作流程解决方案。